Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes
Yane Costa Chaves, Karina Genaro, Cristina Aparecida Jark Stern, Gisele de Oliveira Guaita, José Alexandre S. Crippa, Joice Maria da Cunha, Janaína Menezes Zanoveli
Topics & Concepts
CannabidiolAnxiogenicDiabetes mellitusMedicineInternal medicineElevated plus mazeImipramineHippocampusStreptozotocinType 2 diabetesPrefrontal cortexEndocrinologyInsulinAnxietyPharmacologyPsychiatryAnxiolyticCannabisAlternative medicinePathologyCognitionCannabis and Cannabinoid ResearchPancreatic function and diabetesDiabetes Management and Research